Sclareol Inhibits Hypoxia-Inducible Factor-1α Accumulation and Induces Apoptosis in Hypoxic Cancer Cells
Purpose: The hypoxia in solid tumors is associated with the resistance to chemo/radiotherapy.Hypoxia-inducible factor-1 (HIF-1) plays a key role in cell remodeling to hypoxia. Therefore, theinhibition of HIF-1 accumulation is considered a hopeful strategy for the treatment of cancer.Here, we aimed t...
Main Authors: | Somayeh Vandghanooni, Zahra Farajzadeh Vahid, Ailar Nakhlband, Mir Babak Bahadori, Morteza Eskandani |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2022-05-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-12-593.pdf |
Similar Items
-
The bioactivities of sclareol: A mini review
by: Jianbo Zhou, et al.
Published: (2022-10-01) -
Phytosterols Are Involved in Sclareol-Induced Chlorophyll Reductions in <i>Arabidopsis</i>
by: Asma Ben Hmidene, et al.
Published: (2023-03-01) -
From (-)-sclareol to Norlabdane Heterocyclic Hybrid Compounds
by: Alexandru Ciocarlan
Published: (2022-12-01) -
Investigating the effect of Sclareol on IRE-1 and PERK genes the pathway of reticulandaplasmic system stress in gastric cancer cells MKN-45
by: Elmira Aboutalebi, et al.
Published: (2020-02-01) -
Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma
by: Ana Stepanović, et al.
Published: (2024-05-01)